Cendrowski, W. “Interferon beta and glatiramer acetate modify over two decades the course of relapsing-remitting multiple sclerosis?”. European Journal of Clinical and Experimental Medicine, vol. 8, no. 3, Sept. 2010, pp. 330–337, https://journals.ur.edu.pl/ejcem/article/view/13041.